Table 2.

Distribution of HPV genotypes in different age groups.

HPV genotypes	<20	20–29	30–39	40–49	50–59	60–69	>=70	Positive rate in 7,286 patients (n%)	95% CI
High-risk HPV
HPV16	20	134	285	332	324	155	28	1,278 (17.54)	16.67–18.43
HPV18	10	61	86	127	89	34	6	413 (5.67)	5.15–6.22
HPV26	1	4	6	8	7	5	0	31 (0.43)	1.58–2.22
HPV31	4	12	35	41	33	9	3	137 (1.88)	1.58–2.22
HPV33	3	26	66	78	75	39	10	297 (4.08)	3.63–4.56
HPV35	1	18	23	35	24	13	1	115 (1.58)	1.30–1.89
HPV39	10	68	108	94	69	30	2	381 (5.23)	4.73–5.77
HPV45	5	12	14	15	15	7	0	68 (0.93)	0.73–1.18
HPV51	18	70	118	103	70	31	5	415 (5.70)	5.17–6.25
HPV52	18	207	419	517	352	130	31	1,674 (22.98)	22.01–23.96
HPV53	6	65	128	171	133	35	6	544 (7.47)	6.87–8.09
HPV56	4	36	53	60	82	37	8	280 (3.84)	3.41–4.31
HPV58	15	120	235	337	224	97	13	1,041 (14.29)	13.49–15.11
HPV59	7	34	57	55	49	15	3	219 (3.01)	2.62–3.42
HPV66	4	32	59	55	53	16	3	222 (3.05)	2.67–3.48
HPV68	3	32	62	87	61	19	3	267 (3.66)	3.24–4.12
HPV73	0	0	1	1	0	0	0	2 (0.03)	NA
HPV82	5	23	28	24	27	7	0	114 (1.56)	1.29–1.88
Low-risk HPV
HPV06	18	65	47	57	45	12	2	246 (3.38)	2.97–3.82
HPV11	5	25	32	35	32	16	2	147 (2.02)	1.71–2.37
HPV40	6	10	29	35	17	7	1	105 (1.44)	1.18–1.74
HPV42	5	17	47	58	58	17	3	205 (2.81)	2.45–3.22
HPV43	11	39	49	50	32	15	0	196 (2.69)	2.33–3.09
HPV44	3	24	68	124	80	27	6	332 (4.56)	4.09–5.06
HPV55	0	7	14	28	8	4	0	61 (0.84)	0.64–1.07
HPV61	4	31	61	76	78	9	7	266 (3.65)	3.23–4.11
HPV81	5	47	67	123	97	37	5	381 (5.23)	4.73–5.77
HPV83	0	6	4	4	10	4	1	29 (0.40)	0.27–0.57